Choline Receptor a1(129-145)
Cat.No:CLP0569 Solarbio
CAS:194737-11-6
Molecular Formula:C90H136N22O28S2
Molecular Weight:2038.32
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
{{cart_num}}
My CartCAS:194737-11-6
Molecular Formula:C90H136N22O28S2
Molecular Weight:2038.32
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
Product Type | Peptides |
CAS | 194737-11-6 |
Sequence(1LC) | EIIVTHFPFDEQNCSMK |
Sequence(3LC) | Glu-Ile-Ile-Val-Thr-His-Phe-Pro-Phe-Asp-Glu-Gln-Asn-Cys-Ser-Met-Lys |
Molecular Formula | C90H136N22O28S2 |
Molecular Weight | 2038.32 |
Purity | ≥95% |
Appearance | Lyophilized powder |
Salt Form | Trifluoroacetate salt |
Source | Synthetic |
Storage | Store at -20℃,2 years.(Avoid freeze/thaw cycles) |
Category/Label | Other Peptides |
Background | This fragment of a conserved sequence in nicotinic acetylcholine receptor activates T helper lymphocytes and induces the production of autoantibodies that cause electrophysiologic signs of experimental autoimmune myasthenia gravis. EIIVTHFPFDEQNCSMK may be useful in the development of a peptide-based antigen-specific immunotherapy of myasthenia gravis. |
Reference | [1] ReversalH.Yoshikawa et al., J. Immunol., 159, 1570(1997). |
Unit | Bottle |
Specification | 1mg 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.